The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Communication. Particular areas of interest include:
Pharmacogenetics and Genomics is a unique and innovative journal that covers genetic variation in response to drugs and other chemicals in humans and animals. Its impressive impact factor rating of 4.409 (Pharmacology and Pharmacy, Genetics and Heredity, and Biotechnology & Applied Microbiology, 2008 SCI169; Report) is testament to its quality and standing in this field.Pharmacogenetics and Genomics unites contributions of importance to clinical pharmacologists, biochemists, geneticists, epidemiologists and molecular biologists. The journal publishes studies that identify and characterize polymorphic genes encoding drug metabolizing enzymes, drug receptors and drug transporters. Coverage also includes papers on the effects of gene expression on the disposition and metabolism of foreign chemicals.Full text online at www.pharmacogeneticsandgenomics.com.
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Pharmacogenomics aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.
Pharmacognosy Magazine (Phcog Mag.) is Published Quarterly, Pharmacognosy Magazine (Phcog Mag.) serves the need of different scientists and others involved in medicinal plant research and development. Each issue covers different topics in natural product drug discovery, and also publishes manuscripts that describe investigations, clinical reports, methods, techniques and applications of all forms of medicinal plant research and that are of broad readership interest to users in industry, academia, and government. Phcog Mag. is a must-read magazine for medicinal Plant researchers —and it's an Open Access Publication.
Journal of Lie Theory is a journal for speedy publication of information in the following areas: Lie algebras, Lie groups, algebraic groups, and related types of topological groups such as locally compact and compact groups. Applications to representation theory, differential geometry, geometric control theory, theoretical physics, quantum groups are considered as well. The principal subject matter areas according to the Mathematics Subject Classification are 14Lxx, 17Bxx, 22Bxx, 22Cxx, 22Dxx, 22Exx, 53Cxx, 81Rxx.
Pharmacological Research provides a rapid information exchange medium for specialists within the discipline of pharmacology. The journal publishes papers on basic and applied pharmacological research and is proud of its rapid publication of accepted papers.Invited and unsolicited review articles are also featured.Research Areas are:• Biochemical and molecular pharmacology• Cardiovascular pharmacology• Gastrointestinal pharmacology• Clinical pharmacology, if addressing novel mechanisms of action• Respiratory tract pharmacology• Urogenital tract pharmacology• Pharmacology of tissue repair• Neuropharmacology, psychopharmacology, and neuroendocrinology• Chemotherapy and cancer therapy• Immunopharmacology• Pharmacological applications of genomics• Pharmacology of aging• Nutraceuticals, if relevant to human diseaseNote that ethnopharmacological studies generally do not fall into the scope of this journal. Exceptions are made for papers addressing the mechanisms of actions or the clinical applications of worldwide-used natural substances. Clinical studies on commercially-available nutraceuticals are also taken into consideration.Immediate rejection criteria are:1. Ethnopharmacological papers, namely studies that deal with locally-consumed plants.2. In vitro antioxidant activity of plant extracts and pure compounds isolated from them.3. Papers that describe pharmacological activities of plants which are not easily found worldwide, eg, Chinese herbs.4. Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed.5. Papers describing the pharmacological activities of natural compounds are considered only if they identify novel mechanisms of action. In particular, Pharmacol Research does not publish papers that describe• Single dose studies with very few animals, no dose-response studies.• In-vitro assays with single dose or very high dose, measuring only one endpoint.• Repetition of a simple bioassay for yet another extract or plant.
Pharmacological Research Reports (PREREP) is a journal that publishes articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern pharmacological topics.
PREREP publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials). PREREP is a sound-science journal and therefore novelty and perceived impact will not be considered in the evaluation process. However, the journal will focus on quality studies that advance our knowledge and will take measures to guarantee the replicability of the published material.